Fecal PCR test with COVID-19 during endoscopic procedures

Evaluation of a diagnostic COVID-19 infection based on fecal analysis and consideration of the risks in endoscopic procedures - Effect of COVID-19 infection on the gastrointestinal tract considering preventive methods during endoscopic procedures

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051273

Enrollment

Registered

2023-06-06

Start date

2022-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with diagnosed COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed COVID-19 with nasal PCR-positive at Tokyo Medical University Hospital, and obtained informed consent

Exclusion criteria

Exclusion criteria: Patients who could not give consent to participate in this study. Those who have serious complications (heart failure, renal failure, liver failure, respiratory failure) Other patients who are deemed inappropriate to participate in this study.

Design outcomes

Primary

Measure	Time frame
The detection of SARS-Cov-2 in human stool samples in nasal mucosa PCR-positive individuals	—

Countries

Japan

Contacts

Public ContactSakiko Naito

Tokyo Medical University Department of Gastroenterology and Hepatology

sakiko-n@tokyo-med.ac.jp0333426111

Outcome results